CLINICAL_TRIALS
research
· 2015-12-08
Clinical Trial Update: Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)
Summary
This entry describes the RESAPH registry study on sarcoidosis-associated pulmonary hypertension, with the study status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Cincinnati | Conditions: Sarcoidosis, Pulmonary Hypertension | Status: UNKNOWN